Chest wall expansion determines lung volume and functional capacity. Factors determining chest wall expansion include respiratory muscle strength. Accordingly, there may be association among respiratory muscle strength, chest wall expansion, and functional capacity. Thusly, this cross-sectional study identified the relationship between respirato-ry muscle strength, chest wall expansion, and functional capacity. Seventy-six healthy male and female participants aged between 20 to 59 years exhibiting a body mass index of 18.5 to 22.9 kg/m² were enrolled. Inspiratory and expiratory muscle strength were evaluated via maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP), respectively. Chest wall expansion was measured through thoracic circumferences at three different levels; upper, middle, and lower levels with diaphragmatic movement also measured utilizing the circumference of the lower edge of the 10th rib. Functional capacity was evaluated through distance obtained from a 6-min walk test. Results showed that both MIP and MEP were significantly correlated with chest wall expansion at the middle (P=0.005 and P=0.006) and lower (P=0.012 and P=0.020) thoracic levels as well as diaphragmatic movement (both P<0.001). Moreover, both MIP and MEP were significantly related amid the 6-min walk distance (P=0.025 and P<0.001). In conclusion, respiratory muscle strength is positively associated with chest wall expansion, diaphragmatic movement, and functional capacity in healthy participants.

The purpose of this study was to examine changes in body fat, muscle mass, muscle thickness, and physical and cardiorespiratory fitness in overweight and obese individuals following progressive Tabata training. Thirty-six participants were randomly assigned to either the Tabata group (four progressive cycles of body-weight high-intensity intermittent training at 75–85% of maximum perceived exertion, 3 days/week for 12 weeks) or the control group. Body composition, muscle thickness, strength and endurance, and peak oxygen uptake (VO₂peak) were measured at baseline and after the training period and compared between groups. No changes in body fat percentage and fat mass were found, but the waist-to-hip ratio was lower in the Tabata group (p = 0.043). The muscle mass percentages of the right (p = 0.026) and left legs (p = 0.043) increased, while the muscle thicknesses of the biceps, triceps, rectus femoris, and vastus intermedius were increased in the Tabata group (p < 0.05) to a greater extent than in the control group (p < 0.05). Muscle strength and endurance (p < 0.05), as well as VO₂peak (p = 0.006), also increased in the Tabata group. Twelve weeks of modified Tabata training effectively increased muscle mass and thickness and physical and cardiorespiratory fitness, although it did not reduce fat mass in overweight and obese participants. The combination of this training with a dietary intervention may have a more obvious impact.

Long COVID is characterized by persistent symptoms associated with chronic inflammation and oxidative stress. While high-intensity interval training (HIIT) and supplementation with antioxidants such as Triphala have demonstrated individual therapeutic benefits, their combined effects remain unclear. This study aimed primarily to evaluate the effects of an 8-week HIIT program on markers of inflammation, oxidative stress, and exercise-related symptoms in individuals with long COVID, and secondarily to explore whether Triphala supplementation provided additional benefits. A total of 104 participants (aged 18–59 years) were randomized into three groups—control (placebo), HIIT (cycling for 28 min/day, 3 days/week), and combined (HIIT + Triphala, 1000 mg/day)—for 8 weeks. The biomarkers assessed included interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), malondialdehyde (MDA), protein carbonyls, and superoxide dismutase (SOD) activity. Following the intervention, significant reductions in IFN-γ, TNF-α, MDA, protein carbonyls, and rating of perceived exertion were observed in both the HIIT and combined groups (p < 0.05), with no significant differences between the two. SOD activity significantly increased in all groups, including the control group (p < 0.05), with no between-group differences. An 8-week HIIT program appears to be effective in reducing inflammation, oxidative stress, and dyspnea in individuals with long COVID. Triphala supplementation did not provide any additional statistically significant benefit but was safe and well tolerated.

Aim: This study among moderately fit male athletes investigated changes in oxidative stress and antioxidant levels after supplementation with Eri silkworm cornflakes. Method: Male university athletes ( n = 18, age 19–21 years) were enrolled in a randomized crossover trial. They participated in either the supplementation period (consuming 0.20 g protein/kg body weight Eri silkworm daily) or the control period (no supplementation). Each period lasted 4 weeks, with a washout period of 4 weeks in between. Results: Compared to the control period, reduced glutathione concentration ( p = 0.019) and reduced/oxidized glutathione ratio ( p < 0.001) were significantly higher, and oxidized glutathione ( p = 0.018) and malondialdehyde ( p = 0.002) concentrations were significantly lower in the supplementation period. Conclusion: Eri silkworm supplementation as cornflakes for 4 weeks improved oxidative stress and antioxidant status in male university athletes. This supplement may be an alternative to support optimal antioxidant status for athletic individuals. Thai Clinical Trials Registry (TCTR): TCTR20180303003.

This study investigated the effects of asparagus powder supplementation on blood glucose regulation, insulin, lipid profile, and oxidative stress in overweight and obese individuals. Forty-four adults aged 18–59 years participated in a 12-week randomized controlled trial and were randomly assigned to receive either asparagus powder (40 mg/kg/day) or a placebo (maltodextrin, 40 mg/kg/day). Assessments included an oral glucose tolerance test (OGTT), fasting blood glucose (FBG), insulin, homeostasis model assessment of insulin resistance (HOMA-IR) and β-cell function (HOMA-B), lipid profile, and oxidative stress markers (malondialdehyde [MDA], protein carbonyl, and superoxide dismutase [SOD]). In the asparagus group, OGTT at 30 min and low-density lipoprotein cholesterol (LDL-C) significantly decreased, while SOD activity significantly increased (all p < 0.05). In contrast, the placebo group showed significant increases in OGTT at 30 min, insulin, HOMA-IR, HOMA-B, triglycerides (TG), the TG/high-density lipoprotein cholesterol (HDL-C) ratio, and the total cholesterol (TC)/HDL-C ratio (all p < 0.05). Between-group comparisons indicated that FBG, area under the BG curve at 30–120 min, TG, TG/HDL-C, and MDA levels were significantly lower in the asparagus group than in the placebo group (all p < 0.05), whereas OGTT, LDL-C, SOD activity, insulin, HOMA-IR, HOMA-B, and TC/HDL-C did not differ significantly. Other indices, including TC, HDL-C, and protein carbonyl, showed no significant within- or between-group differences. In conclusion, 12 weeks of asparagus powder supplementation partially improved glycemic control, lipid profile, and oxidative stress in overweight and obese individuals. These findings suggest a potential role of asparagus as a complementary nutritional strategy to reduce the risk of diabetes and cardiovascular disease in this population.